financial estimates
Agilent Diagnostics and Genomics Group Revenues up Slightly in Q4 as Overall Sales Decline 9 Percent
The firm reported its Life Sciences and Applied Markets Group's revenues fell 17 percent year over year, but the CEO predicts recovery in 2024.
Bio-Rad Again Lowers Guidance After Q3 Revenue Miss, Sharp Sales Decline in Life Science Segment
Premium
The firm plans to stay the course on its long-term company transformation goals despite the imminent departure of its chief financial officer, one of the plan's architects.
QuidelOrtho Expects Q3 Revenues Well Above Wall Street Estimate
The firm said its preliminary revenues came in above prior expectations due to an earlier-than-expected demand for seasonal respiratory infection testing.
Quanterix Q1 Revenues Fall 4 Percent as Instrument Sales Decline
Product and service and other revenues were both down year over year, while collaboration and grant revenues rose.
Oncocyte Prices $13.9M Stock Offering, Reports 69 Percent Drop in Preliminary Q4 Revenues
The Irvine, California-based molecular diagnostics firm reported $1.1 million in Q4 2022 revenues and $5.6 million in full-year 2022 revenues.
Apr 20, 2022
Abbott Q1 Diagnostics Revenues Climb 32 Percent
Jan 27, 2022
Jan 20, 2022
Jan 13, 2022